(CIDRAP News) – In an effort to expand the pool of antiviral drugs for influenza, the US government yesterday awarded a $102.6 million contract to BioCryst Pharmaceuticals Inc. of Birmingham, Ala., to develop peramivir, a new neuraminidase inhibitor.
(CIDRAP News) – In an effort to stretch the nation's supply of vaccines for a potential influenza pandemic, federal health officials today announced contracts totaling $132.5 million to help three companies develop dose-sparing substances, or adjuvants, to be used with H5N1 flu vaccines.
(CIDRAP News) There's no standard playbook on communicating with the public during an influenza pandemic, but the Centers for Disease Control and Prevention (CDC) is working to educate public health officials and businesses about how to tailor successful messages.
(CIDRAP News) – The Bush administration's new budget proposes adding funds for pandemic preparedness while cutting some support for bioterrorism and local preparedness, drawing mixed reviews from national public health groups.
(CIDRAP News) – A US Food and Drug Administration (FDA) panel today recommended that the agency approve the nation's first H5N1 influenza vaccine, despite new evidence that the vaccine is less protective than reported in a clinical trial last year.
(CIDRAP News) – The Swiss pharmaceutical company Roche announced today it is scaling back production of oseltamivir (Tamiflu) because of waning demand, and simultaneously questioned whether countries stockpiling the drug are buying enough to protect their citizens in the event of an influenza pandemic.
(CIDRAP News) – To encourage the public to join discussions on pandemic influenza preparedness, the US Department of Health and Human Services (HHS) today launched a 5-week blog on the topic in conjunction with a Jun 13 leadership forum.